Sanofi (SNY) News Headlines

▮ More

Date

Headline

9/20/2019 7:17:57 AM Regeneron And Sanofi Say CHMP Adopts Positive Opinion For Dupixent

9/17/2019 1:02:13 AM Happify Health, Sanofi Sign Deal To Bring Prescription Digital Mental Health Therapeutics To Individuals With MS

9/16/2019 1:16:06 AM Sanofi, Abbott To Integrate Glucose Sensing And Insulin Delivery Technologies

9/16/2019 1:04:27 AM Sanofi, Abbott Partner To Integrate Glucose Sensing & Insulin Delivery Technologies

9/15/2019 1:51:47 PM FDA Finds Cancer-causing Impurity In Ranitidine

8/6/2019 2:36:23 AM ALNY To Face FDA In Feb., PODD Ups Outlook Again, Catalysts Galore For XLRN

8/6/2019 1:24:29 AM Sanofi:EU Oks Dupixent For Adolescents With Moderate-to-Severe Atopic Dermatitis

8/6/2019 1:09:01 AM Sanofi Says Dupixent Showed Positive Topline Results In Phase 3 Trial

8/6/2019 1:06:38 AM Sanofi: EC Approves Dupixent For Adolescents With Atopic Dermatitis

7/29/2019 8:09:12 AM EARNINGS SUMMARY: Details of Sanofi Q2 Earnings Report

7/29/2019 1:59:37 AM Sanofi Q2 Business Net Income Rises; Lifts 2019 Guidance - Quick Facts

7/29/2019 1:35:17 AM Sanofi Q2 Business EPS Up 4.8% To EUR 1.31

7/27/2019 11:35:08 AM Sanofi Terminates Partnership With Lexicon To Develop Diabetes Drug

7/23/2019 8:08:59 AM Opiant Pharma Inks Deal With Sanofi For Manufacturing OPNT004 For Treatment Of Acute Cannabinoid Overdose

7/23/2019 2:10:56 AM Sanofi Gains US OTC Rights For Tamiflu To Treat Influenza - Quick Facts

7/23/2019 1:47:22 AM Sanofi Signs Strategic Deal For Exclusive US Over-the-counter Rights To Tamiflu In Flu Care

7/11/2019 7:12:00 AM Schrödinger Receives Milestone Payment From Sanofi Collaboration

7/11/2019 7:08:22 AM Schrödinger Receives Preclinical Milestone Payment From Sanofi

7/10/2019 1:28:49 AM Sanofi: FDA To Review Isatuximab As Potential Treatment For RRMM

7/10/2019 1:05:55 AM Sanofi Says FDA To Review Isatuximab For Relapsed/refractory Multiple Myeloma